Speaker Profile

M.D., Chief Medical Officer, Senior Vice President, Quest Diagnostics

Dr. Wohlgemuth oversees R&D, Medical, Employee Health and Employer Health and Wellness for Quest Diagnostics and is a member of the senior management team. Prior to joining Quest Diagnostics Dr. Wohlgemuth held the position of Director of Clinical Diagnostics, Immunology, Tissue Growth and Repair at Genentech as well as Global Development Team Leader – Ocrulizumab. He was co-founder and Chief Medical Officer for the molecular diagnostics company XDx, where he was awarded Technology Pioneer 2005 at the World Economic Forum in Davos. Jay obtained his bachelor’s degree in biology at Harvard College and received his medical degree from Stanford where he also served a fellowship in cardiovascular medicine. He is on the Board of Directors of the Personalized Medicine Coalition, Q2 Solutions and Diagnostic Labs of Oklahoma and serves as trustee of the Anne and Henry Zarrow Foundation, a charitable foundation focused on supporting delivering health care and social services.

Presentation Title and Company Description

Clinical Dx Showcase: Population Based Precision Medicine
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.

Don't Miss Important Precision Medicine Updates

PMWC is the most comprehensive precision medicine conference. To receive the lastest news and updates from the field, subscribe to the newsletter here.

View the top 3 talks from PMWC here (password: top-videos).